CIK: 1791249 - Address: C/O Tarsus Pharmaceuticals, Inc., 15440 Laguna Canyon Road, Suite 160, Irvine, CA 92618
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/17/22 16:51
6/15/22
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADM.d00.000401,308D
5/9/22 16:42
5/5/22
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADP1,35013.50010081,304I
12/3/21 18:56
12/1/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS-14424.680-601,204D
11/3/21 19:00
11/1/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS-16227.820-601,210D
10/14/21 16:48
10/12/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS-14826.270-601,216D
10/12/21 18:47
10/8/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS-525.030001,221D
9/3/21 18:53
9/1/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS-14725.240-601,222D
8/12/21 17:27
8/11/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS-1625.150-101,227D
8/10/21 16:55
8/6/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS.m-9625.000-401,228D
8/6/21 16:16
8/5/21
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagAckermann MichaelCADS-3525.000-101,232D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact